It would be an egregious act on Kazia's part to raise money at these prices. (If they do an offering before GDC or Cantrixil clinical readouts, then they're not optimistic about the results).
Hopefully for shareholders, the GDC 0084 results are good, then a CR.
KZA Price at posting:
37.0¢ Sentiment: Buy Disclosure: Held